The collaboration with the CDMO further solidifies Bio-Works’ position as a trusted supplier of high-quality and scalable purification solutions for the biopharma industry. The order will see Bio-Works’ WorkBeads™ products integrated into the client’s production processes, enhancing the efficiency and quality of biomolecule purification at a commercial scale.

Lone Carlbom, CEO of Bio-Works Technologies, commented on the order:
"This significant production-scale order is a testament to the quality and reliability of our WorkBeads™ resins. We are proud to partner with such a reputable CDMO in Sweden, and this collaboration underscores our ongoing commitment to delivering innovative solutions that meet the growing demands of the biopharmaceutical industry. As the industry continues to expand, we are well-positioned to support our partners in achieving excellence in bioprocessing."
This order marks another key milestone in Bio-Works Technologies’ growth trajectory, as the company continues to expand its footprint within the global biopharma purification market. The use of Bio-Works' proprietary technology in production processes will enable faster, more efficient manufacturing of biotherapeutics, ultimately benefiting patients around the world.